Risk of rifampin resistance emergence after incomplete first-line tuberculosis treatment. Dupuis GN, Dolynska M, Chiang SS, Horsburgh CR Jr, et al. Eur Respir J 2025 Jul 3:2500902. doi: 10.1183/13993003.00902-2025.

Read + Share

Amedeo Smart

Independent Medical Education

Dupuis GN, Dolynska M, Chiang SS, Horsburgh CR Jr, et al. Risk of rifampin resistance emergence after incomplete first-line tuberculosis treatment. Eur Respir J 2025 Jul 3:2500902. doi: 10.1183/13993003.00902-2025.
PMID: 40610055